SCHEMBL982312

SCHEMBL982312

CN(C)CCCc1[c]cccc1CC(=O)N1CCC(c2ccc(F)cc2)=N1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAOB P27338 2/20 0.39
ALDH1A1 P00352 2/20 0.38
HPGD P15428 2/20 0.38
RAB9A P51151 1/20 0.38
SMN1; SMN2 Q16637 1/20 0.38
HCRTR1 O43613 1/20 0.33
PGR P06401 2/20 0.33
KIF11 P52732 1/20 0.32
LMNA P02545 2/20 0.31
NPSR1 Q6W5P4 2/20 0.31
KDM4E B2RXH2 1/20 0.31
S1PR2 O95136 1/20 0.31
GLA P06280 1/20 0.31
GAA P10253 1/20 0.31
MAPT P10636 1/20 0.31
HTT P42858 1/20 0.31
KMT2A Q03164 1/20 0.31
ATM Q13315 1/20 0.31
TDP1 Q9NUW8 1/20 0.31
MET P08581 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL980138 0.90 HCRTR1 (0.35) MAOBALDH1A1HPGDRAB9ASMN1; SMN2
SCHEMBL980746 0.88 KIF11 (0.42) KIF11KCNH2
SCHEMBL980244 0.84 MAOA (0.40) MAOBALDH1A1HPGDRAB9ASMN1; SMN2
SCHEMBL980074 0.81 MET (0.44) ALDH1A1HPGDLMNANPSR1KDM4E
SCHEMBL979241 0.75 MET (0.40) ALDH1A1RAB9AKIF11TDP1MET
SCHEMBL982788 0.74 MAOB (0.47) MAOBALDH1A1HPGDRAB9ASMN1; SMN2
SCHEMBL981265 0.72 KIF11 (0.45) ALDH1A1KIF11KMT2AMET
SCHEMBL1027180 0.72 MAOB (0.48) MAOBALDH1A1HPGDRAB9ASMN1; SMN2
SCHEMBL980870 0.71 MAOB (0.53) MAOBALDH1A1HPGDRAB9ASMN1; SMN2
SCHEMBL5046797 0.70 MAOB (0.40) MAOBALDH1A1HPGDRAB9ASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7875644-B2 tyrosine kinase inhibitors, in particular Met kinase; antitumor agents;1-(Benzo-1,2,5-thiadiazol-5-ylmethylcarbonyl)-3-(2,4-dimethoxyphenyl)-4,5-dihydro-1H-pyrazole; leukemia, carcinomas MERCK PATENT GMBH (DE) 2011-01-25 US claimed